Projects
Search from 1157 projects:
1157 Project(s)
SASL 38 Swiss Cohort Study on Autoimmun Hepatitis
Sep 14, 2016Research project in which biological material is sampled from humans and health-related personal data is collected for research.
Clinical Studies - Sep 14, 2016 - Sep 14, 2022
Automatically Closed
Project leader: Semela David
Members: Stillhard Roman
SASL 39 Swiss Cohort Study on Primary Biliary Cholangitis
Sep 14, 2016Research project in which biological material is sampled from humans and health-related personal data is collected for research.
Clinical Studies - Sep 14, 2016 - Sep 14, 2022
Automatically Closed
Project leader: Semela David
Members: Stillhard Roman
A 52-week, multicenter, randomized, double-blind, placebocontrolled study to assess the efficacy and safety of QAW039 when added to existing asthma therapy in patients with uncontrolled severe asthma
Sep 11, 2016Das Ziel dieser Studie ist es, die Wirksamkeit und Sicherheit von QAW039 (150 mg und 450 mg einmal täglich) im Vergleich zu Placebo zu bestimmen, wenn es Patienten mit unzureichend kontrolliertem schweren Asthma und hoher Anzahl an Eosinophilen (Eosi...
Clinical Studies - Sep 11, 2016 - Mar 31, 2018
Automatically Closed
Project leader: Brutsche Martin
Members: Baty Florent, Schlotter Sandra
CA209451: Randomized, Multicenter, Double-Blind, Phase 3 Study of Nivolumab, Nivolumab in Combination with Ipilimumab, or Placebo as Maintenance Therapy in Subjects with Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) after Completion of Platinum-based First Line Chemotherapy. CheckMate 451
Sep 7, 2016This is a randomized, double-blind, three-arm, multicenter, Phase 3 study in adult subjects with ED-SCLC, who achieve Stable Disease, Partial Response or Complete Response after completion of platinum based first line chemotherapy. Approximately 810...
Clinical Studies - Sep 7, 2016 - Nov 30, 2020
Automatically Closed
Project leader: Früh Martin
Monitoring of Patients’ Needs, Professional Triggers and delivered Basic Palliative Care Interventions in Routine inpatient and ambulatory of Advanced Incurable Cancer Patients: A sub-study to pilot the clinical practice tool – ESMO patient guide with KIPCC log
Sep 1, 2016Increasing evidence from randomized studies (Level A) shows that quickly integrated palliative care interventions in the treatment of cancer patients may improve the quality of life of patients and relatives, illness and prognosis understanding and s...
Clinical Studies - Sep 1, 2016 - Mar 31, 2017
Automatically Closed
Project leader: Strasser Florian
Members: Domeisen Benedetti Franzisca
REGAIN CONTROL Toujeo
Sep 1, 2016Eine 26-wöchige, randomisierte, offene, zweiarmige, pragmatische Parallelgruppenstudie unter realen Bedingungen zur Beurteilung des klinischen und gesundheitsrelevanten Nutzens des Wechsels zu Toujeo® im Vergleich zum als Therapiestandard geltenden I...
Clinical Studies - Sep 1, 2016 - Mar 14, 2018
Completed
Project leader: Aczel Stefan
Members: Räss Andrea
An open-label Phase 1/2a study of BAL101553 adminis-tered as 48-hour intravenous infusions in adult patients with advanced solid tumors
Aug 19, 2016The primary objectives of this study are to determine the maximum tolerated dose (MTD) and to characterize dose-limiting toxicities (DLTs) of BAL101553, administered as an intravenous (IV) infusion over 48 hours on study Days 1, 8 and 15 of a 28-day...
Clinical Studies - Aug 19, 2016 - Jan 31, 2018
Automatically Closed
Project leader: Jörger Markus
BI1199.214 Senscis
Aug 9, 2016A double blind, randomised, placebo-controlled trial evaluating efficacy and safety of oral nintedanib treatment for at least 52 weeks in patients with ‘Systemic Sclerosis associated Interstitial Lung Disease’(SSc-ILD). A trial to compare nintedanib...
Clinical Studies - Aug 9, 2016 - Sep 8, 2017
Completed
Project leader: Müller Rüdiger
Members: Forrer Silvia, Bartz-Batliner Mira, Hutz Carina Liane, Schmidig Kathrin
Entyvio PASS Study
Jul 28, 2016Entyvio (vedolizumab) long-term safety study: An international observational prospective cohort study comparing vedolizumab to other biologic agents in patients with ulcerative colitis or Crohn’s Disease. This is a prospective, observational, multi-...
Clinical Studies - Jul 28, 2016 - Jun 28, 2022
Automatically Closed
Project leader: Brand Stephan
Members: Dora Barbara, Knellwolf Christina, Sulz Michael, Krieger-Grübel Claudia
Phase II Trial of Pembrolizumab (MK-3475) in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated with Chemotherapy (KEYNOTE-199) / MK-3475-199 Pembro Prostata
Jul 27, 2016This is a nonrandomized, multinational, open-label trial of pembrolizumab (MK-3475) in subjects with metastatic cas-tration-resistant prostate cancer (mCRPC) previously treated with docetaxel-based chemotherapy. The trial will be conducted in conform...
Clinical Studies - Jul 27, 2016 - Jun 30, 2019
Automatically Closed
Project leader: Omlin Aurelius
A Phase 1/2a Dose Escalation and Cohort Expansion Study for Safety, Tolerability, and Efficacy of BMS-986156 Administered Alone and in Combination with Nivolumab (BMS-936558, anti PD-1 Monoclonal Anti-body) in Advanced Solid Tumors
Jul 21, 2016This is a Phase 1/2a, open-label study of BMS-986156 administered as a single agent and in combination with nivolumab in subjects with advanced solid tumors. The study will be conducted in 4 parts. Parts A and B will consist of dose escalation with B...
Clinical Studies - Jul 21, 2016 - Sep 30, 2017
Automatically Closed
Project leader: Jörger Markus
Immunmonitoring of patients before, during and after immunotherapy to predict anti-tumor response in melanoma and non-small cell lung cancer (IMIT)
Jul 15, 2016
Clinical Studies - Jul 15, 2016 - Oct 15, 2019
Automatically Closed
Project leader: Flatz Lukas
Members: Diem Stefan
Constructing accessory lymph nodes in situ for control of mammary carcinoma
Jul 1, 2016Lymph nodes (LNs) are situated at junctures of the blood vascular and the lymphatic system where antigens drain from peripheral tissues via afferent lymphatics. The decision whether and how immune responses against tumors are initiated and maintained...
Fundamental Research - Jul 1, 2016 - Jun 30, 2019
Automatically Closed
Project leader: Ludewig Burkhard
Members: Cupovic Jovana
A multicentre, double blind, randomised, placebo-controlled, Phase II trial to evaluate Resminostat for maintenance treatment of patients with advanced stage (Stage IIB-IVB) mycosis fungoides (MF) or Sézary Syndrome (SS) that have achieved disease control with systemic therapy – the RESMAIN Study
Jun 25, 2016
Clinical Studies - Jun 25, 2016 - Dec 31, 2027
Ongoing
Project leader: Cozzio Antonio
eSATIS: Early Sleep Apnea Treatment in Stroke: A Randomized, Rater-Blinded, Clinical Trial of Adaptive Servo-Ventilation
Jun 20, 2016The prevalence of Sleep Disordered Breathing (SDB) after acute stroke is high (over 50% of affected patients in more than 20 studies). SDB after stroke has been found to be associated with a faster progression of stroke severity, with higher blood pr...
Clinical Studies - Jun 20, 2016 - Jun 20, 2018
Automatically Closed
Project leader: Flügel Dominique
Members: Kägi Georg
AdaptResponse
Jun 17, 2016Studie mit einem System für die kardiale Resynchronisationstherapie (CRT - Cardiac Resynchronization Therapy) mit der aCRT-Funktion zur optimierten Behandlung von Herzinsuffizie
Clinical Studies - Jun 17, 2016 - Dec 31, 2022
Completed
Project leader: Ammann Peter
Members: Vetsch Susanne
An Open Label Biomarker Driven Phase II Clinical Trial of Abiraterone Acetate (AA) Re-Challenge in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior Response to AA (Abi-RE)
Jun 12, 2016Clinical Trial with an IMP, risk category B according to HRA. Abiraterone acetate (AA) is a standard treatment option both in chemotherapy naïve and docetaxel pre-treated men with metastatic castrate-resistant prostate cancer (CRPC). With the approva...
Clinical Studies - Jun 12, 2016 - Dec 31, 2017
Automatically Closed
Project leader: Omlin Aurelius
SAKK GRAALL 2014: Multicenter trial for the treatment of Acute Lymphoblastic Leukemia (ALL) in younger adults (18-59 years)
Jun 3, 2016GRAALL-2014 follows the GRAALL-2003 and 2005 trials. The GRAALL-2014 trial is subdivided in three sub-studies: GRAALL-2014/B, GRAALL-2014/T and GRAAPH-2014respectively for patients with B-lineage Ph-negative ALL, T-lineage ALL or Ph+ ALL. France, S...
Clinical Studies - Jun 3, 2016 - May 31, 2026
Ongoing
Project leader: Silzle Tobias
Members: Quinter Janine
A Prospective, Multicenter, Observational, Single-arm European Registry on the ACE Reperfusion Catheters and the Penumbra System in the Treatment of Acute Ischemic Stroke
Jun 2, 2016Study Objective: To observe the safety and effectiveness of the ACE Reperfusion Catheters and the Penumbra System in patients with acute ischemic stroke from large vessel occlusion, treated with the ADAPT technique in site routine practice. Study De...
Clinical Studies - Jun 2, 2016 - May 31, 2017
Completed
Members: Vehoff Jochen, Kägi Georg, Müller Anna
Longterm ureteral stenting: Assessment of stent-associated morbidity, associated costs and impact of biofilms
Jun 2, 2016Untersuchung von Biofilmen bei Patienten unter Langzeitschienung des Harnleiters. Untersuchung der assoziierten Morbidität.
Clinical Studies - Jun 2, 2016 - May 18, 2018
Automatically Closed
Project leader: Betschart Patrick
Members: Abt Dominik, Schmid Hans-Peter, Zumstein Valentin, Sauter Rafael, Staubli Sergej